Essential content of evidence‐based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update. (3rd July 2016)

• Record Type: Journal Article
• Authors: Kubota, Yoshinobu; Nakaigawa, Noboru
• Other Names: Nishiyama Hiroyuki investigator.; Hinotsu Shiro investigator.; Ogawa Osamu investigator.; Inoue Keiji investigator.; Ozono Seiichiro investigator.; Kikuchi Eiji investigator.; Miki Tsuneharu investigator.; Matsuyama Hideyasu investigator.; Fujioka Tomoaki investigator.; Ohyama Chikara investigator.; Fujimoto Hiroyuki investigator.; Azuma Haruhito investigator.; Habuchi Tomonori investigator.; Nakagawa Masayuki investigator.; Mizowaki Takashi investigator.; Matsui Yoshiyuki investigator.; Kobayashi Takashi investigator.; Osaka Kimito investigator.; Furuse Hiroshi investigator.; Naya Yoshio investigator.; Obara Wataru investigator.; Koike Takuya investigator.; Yoneyama Takahiro investigator.; Hashimoto Yasuhiro investigator.; Hatakeyama Shingo investigator.; Imai Atsushi investigator.; Nakanishi Hiroyuki investigator.; Hara Tomohiko investigator.; Tsuchiya Norihiko investigator.; Inoue Takamitsu investigator.; Ohta Junichi investigator.; Suzuki Kotaro investigator.; Fujikawa Atsushi investigator.; Umemoto Susumu investigator.; Izumi Koji investigator.; Noguchi Sumio investigator.;
• Is Part Of: International journal of urology. Volume 23:Number 8(2016)
• Page Start: 640
• Page End: 645
• Publication Date: 2016-07-03
• Subjects: bladder cancer -- clinical practice guideline -- Japanese Urological Association -- treatment algorithm; Urology -- Periodicals; Genitourinary organs -- Periodicals; Urologic Diseases -- Periodicals; 616.6005
• DOI: 10.1111/iju.13141
• Languages: English
• ISSNs: 0919-8172

Abstract

Abstract: The Japanese Urological Association revised the clinical practice guidelines for bladder cancer in April 2015. This was the first update carried out in the 6 years since the development of the initial clinical practice guidelines for bladder cancer in 2009. The descriptive content was revised, and additions were made with a focus on new‐found evidence and advances in the latest medical practices, and on the basis of the increasingly aging population observed in the underlying social context in Japan. An algorithm for the treatment of bladder cancer has been presented as a new trial. In the present article, we will introduce the essential contents and clinical questions that address the present revisions.